Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
#updated 9/23/20 User-agent:* Disallow: /hcp-interstitial Disallow: /hcp/exitsite Disallow: /consumer/exitsite Sitemap: http://www.zaltrap.com/sitemap.xml # End |
Title | Metastatic Colorectal Cancer (mCRC) Treatment | ZALTRAP® |
Description | Your Guide to ZALTRAP® ZALTRAP is a cancer drug given with chemotherapy (FOLFIRI) for mCRC patients previously treated with oxaliplatin. See Important Safety Information and full Prescribing Information including Serious Side |
Keywords | ZALTRAP, metastatic colorectal cancer treatment |
WebSite | zaltrap.com |
Host IP | 192.103.124.40 |
Location | United States |
Site | Rank |
US$1,737
Last updated: 2023-05-13 08:34:04
zaltrap.com has Semrush global rank of 0. zaltrap.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. zaltrap.com receives approximately 200 unique visitors each day. Its web server is located in United States, with IP address 192.103.124.40. According to SiteAdvisor, zaltrap.com is safe to visit. |
Purchase/Sale Value | US$1,737 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$48 |
Yearly Ads Revenue | US$577 |
Daily Unique Visitors | 13 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
zaltrap.com. | A | 900 | IP: 192.103.124.40 |
zaltrap.com. | NS | 900 | NS Record: ns4.sanofi-synthelabo.com. |
zaltrap.com. | NS | 900 | NS Record: ns1.sanofi-synthelabo.com. |
zaltrap.com. | NS | 900 | NS Record: ns2.sanofi-synthelabo.com. |
zaltrap.com. | NS | 900 | NS Record: ns3.sanofi-synthelabo.com. |
zaltrap.com. | MX | 900 | MX Record: 10 mailerb.sanofi.com. |
zaltrap.com. | MX | 900 | MX Record: 10 mailera.sanofi.com. |
For U.S. Residents Only Important Safety Information Healthcare Professional Web Site Full Prescribing Information For U.S. Residents Only See full Prescribing Information MENU Home About ZALTRAP How it works Getting started Side effects Resources Home About ZALTRAP How it works Getting started Side effects Resources and tags, as close as possible to the opening tag. Creation Date: 05/30/2013 --> Your Guide to ZALTRAP ® (ziv-aflibercept) ZALTRAP, a vascular endothelial growth factor inhibitor, in combination with fluorouracil, leucovorin, irinotecan (FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer that is resistant to or has progressed following an oxaliplatin-containing regimen. You or a loved one may be considering therapy with ZALTRAP, also known as ziv-aflibercept, which is an FDA-approved anti-cancer medicine given in combination with a chemotherapy regimen called FOLFIRI (foal-feer-ee) to treat colorectal cancer that has spread. FOLFIRI |
HTTP/1.1 301 Moved Permanently Content-Length: 0 Location: http://www.zaltrap.com/ Date: Tue, 21 Dec 2021 01:44:38 GMT HTTP/1.1 200 OK Cache-Control: private Content-Length: 19635 Content-Type: text/html; charset=utf-8 Date: Tue, 21 Dec 2021 01:44:38 GMT |
Domain Name: ZALTRAP.COM Registry Domain ID: 1554759291_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-05-03T05:20:29Z Creation Date: 2009-05-07T12:21:19Z Registry Expiry Date: 2023-05-07T12:21:19Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.SANOFI-SYNTHELABO.COM Name Server: NS2.SANOFI-SYNTHELABO.COM Name Server: NS3.SANOFI-SYNTHELABO.COM Name Server: NS4.SANOFI-SYNTHELABO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:37:52Z <<< |